Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Adtalem & CDEMA Unite To Boost Caribbean's Disaster Issues

Published 12/12/2019, 09:07 PM
Updated 07/09/2023, 06:31 AM

Caribbean Center for Disaster Medicine (“CCDM”), a unit of Adtalem Global Education’s (NYSE:ATGE) American University of the Caribbean School of Medicine, has partnered with Caribbean Disaster Emergency Management Agency (“CDEMA”) to enhance the region’s disaster-related medicine education and training.

With this collaboration CDEMA and CCDM will put together stakeholders as well as resources to train professionals and enable the public to prepare for disaster-related medical and healthcare issues.

It will provide educational pathway program for safeguarding as well as promoting the overall health of people of Sint Maarten before, during and after a disaster.

Health Care & International Institutions’ Performance Bodes Well

American University of the Caribbean (“AUC”) School of Medicine — one of the medical and veterinary schools of Adtalem — provides training to physicians. The institute’s service is enhanced by international learning experiences, a diverse learning community as well as emphasis on social accountability and engagement.

AUC’s collaborative learning environment features multitude student organizations, small class sizes, international training opportunities and a team-based learning culture. This enables doctors to be part of a team that delivers empathetic, extraordinary care to a diverse patient population.

Notably, Adtalem’s health care and international institutions have shown significant improvement in revenues and profitability since fiscal 2013. The company’s fiscal 2019 revenues increased primarily on higher contribution from the Medical and Healthcare as well as Financial Services segments. In the first quarter of fiscal 2020, revenues in the segment rose 2.7% from the year-ago quarter’s figure. Precisely, Medical and Veterinary schools’ revenues rose 2.9% year over year in the fiscal first quarter.

Price Performance

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .



Shares of Adtalem have declined 26% so far this year against the industry’s 38.9% growth. The company has been recording lower profits in the past few quarters due to certain restructuring charges related to the closing of the Ross University School of Medicine campus in Dominica. Also, real estate consolidations and increased marketing-related expenses are other factors that led to the downside.

Nevertheless, collaborations and strategic initiatives undertaken are expected to drive growth and enable the company regain momentum. Notably, Adtalem expects to generate revenue growth in the range of 5-7% in the fiscal 2020.

Zacks Rank & Key Picks

Currently, Adtalem carries a Zacks Rank #5 (Strong Sell).

Some better-ranked stocks in the Zacks Consumer Discretionary sector are Career Education Corporation (NASDAQ:CECO) , New Oriental Education & Technology Group Inc (NYSE:EDU) and JAKKS Pacific, Inc (NASDAQ:JAKK) , each sporting a Zack Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Career Education’s earnings surpassed estimates in all of the trailing four quarters, the average being 23.9%.

New Oriental’s current-year earnings are expected to rise approximately 33.3%.

JAKKS Pacific has three-five year expected earnings per share growth rate of 5%.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


New Oriental Education & Technology Group, Inc. (EDU): Free Stock Analysis Report

Career Education Corporation (CECO): Free Stock Analysis Report

JAKKS Pacific, Inc. (JAKK): Free Stock Analysis Report

Adtalem Global Education Inc. (ATGE): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.